Vir Biotechnology & Gilead Announce Phase 2 Clinical Trial Collab for Functional Cure of Hepatitis B Virus
by Press Release from Outbreak News Today on (#5CSR5)
Gilead Sciences, Inc. and Vir Biotechnology, Inc. announced this week that the companies have entered into a clinical collaboration to evaluate novel therapeutic combination strategies aimed at developing a functional cure for chronic hepatitis B virus (HBV). The companies plan to initiate a Phase 2 trial evaluating combination therapy for both treatment-experienced and treatment-naive people [...]
The post Vir Biotechnology & Gilead Announce Phase 2 Clinical Trial Collab for Functional Cure of Hepatitis B Virus appeared first on Outbreak News Today.